| 941/1507 | US=84 / Biol/Mol Seoane J. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: TGF-B signaling in homeostasis and cancer. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 23-35. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 942/1507 | US=84 / Biol/Mol Todorovic V, Rifkin DB. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: TGF-B availability: latent TGF-B and latent TGF-B binding proteins. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 37-55. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; LATENCIA PROTEINA ASSOCIADA; LATENCIA ASSOCIADA PROTEINA LATENTE; PROTEINA TGF-B DE LIGACAO; MATRIZ EXTRACELULAR; PLASMINA; THROBOSPODIN-1 |
| 943/1507 | US=84 / Biol/Mol Hyytiäinen M, Koli K, Keski-Oja J. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: biological functions of latent TGF-B-binding and activation of TGF-B. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 57-75. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 944/1507 | US=84 / Biol/Mol Atfi A, Bourgeade MF. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: regulators of smad2/3 transcription and phosphorylation. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 77-90. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. FOSFORILACAO SMAD; TRANSLOCACAO NUCLEAR DE SMADS; ATIVIDADE TRANSCRICIONAL SMAD; COATIVADORES SMADS; SMADS COREPRESSORS |
| 945/1507 | US=84 / Biol/Mol Kim SS, Shuman C, Mishra L. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: Interaction of smad4 and embryonic liver fodrin-B-spectrin in hyperplasia, neoplasia, and tumor suppression. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 91-103. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; SMAD4; CAMUNDONGOS KNOCKOUT; TUMORIGENESE; FATOR TRANSFORMADOR DE CRESCIMENTO |
| 946/1507 | US=84 / Biol/Mol Liu F. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: regulation of smad activity by phosphorylation. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 105-23. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; SMAD; FOSFORILACAO; FOSFATASE; QUINASE DO RECEPTOR; MAP QUINASE; CDK; CANCER |
| 947/1507 | US=84 / Biol/Mol Xu L. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: nuclear targeting of TGF-B-activated smads in normal and tumor biology. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 125-37. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. IMPORTACAO NUCLEAR; EXPORTACAO NUCLEAR; NUCLEO-CITOPLASMATICO; SMAD; TGF-B |
| 948/1507 | US=84 / Biol/Mol Xu L. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: ski, snoN, and aKt as negative regulators of smad activity: balancing cell death and cell survival regulatorsnuclear targeting of TGF-B-activated smads in normal and tumor biology. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 139-53. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 949/1507 | US=84 / Biol/Mol Zhang YE, Yamashita M. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: transforming growth factor-B in cancer therapy: smurfs in TGF-B signaling and regulation of bone homeostasis and cancer. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 155-67. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 950/1507 | US=84 / Biol/Mol Jin Q, Gao G, Mulder KM. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: involvement of km23 dynein light chains in TGF B signaling. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 169-84. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. KM23; TGF-B; DINEINA; TRANSDUCAO DE SINAL; CANCER; FATOR DE CRESCIMENTO; PROTEINA MOTOR; DYNLRB; SMAD; TRAFICO |
| 951/1507 | US=84 / Biol/Mol Bhowmick NA. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: TGF-B signaling in fibroblastic cells and oncogenesis. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 185-98. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; CELULAS ESTROMAIS; MESENQUIMA; PANCA; PROSTATA; TUMORIGENESE |
| 952/1507 | US=84 / Biol/Mol Kim TA, Kim SJ. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: mechanisms of TGF-B-induced apoptosis in cancer cells. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 199-211. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 953/1507 | US=84 / Biol/Mol Gold LI, Lecanda J. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: mechanisms of cell cycle regulation by TGF-B disabled in cancer. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 213-42. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. P27KIP1; CKS1; SKP2; CANCRO ENDOMETRIAL; UBIQUITINA-PROTEASSOMA |
| 954/1507 | US=84 / Biol/Mol Band A, Laiho M. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: transforming growth factor-B in cancer therapy. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 243-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-BETA; SMAD; TRANSDUCAO DE SINAL; SNON; PROTEASSOMA; UBIQUITINA; SUMO; DEGRADACAO |
| 955/1507 | US=84 / Biol/Mol Thuault S, Valcourt U, Kowanetz M, Moustakas A. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: TGF-B and smad signaling in transcriptome reprogramming during EMT. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 259-73. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. ADERENTES JUNCAO; EMT; METASTASE; POLARIDADE; JUNCAO APERTADA |
| 956/1507 | US=84 / Biol/Mol Stuelten CH, Roberts AB, Stetler-Stevenson WG. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: functional interactions between MMPs and TGF-B in normal and tumor tissue. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 275-92. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; MMP; TUMOR; INTERACAO ESTROMA TUMORAL; SINALIZACAO CELULAR |
| 957/1507 | US=84 / Biol/Mol Liu IM, Schilling SH, Wang XF. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: Cooperation between TGF-B and Wnt pathway components in regulating mesenchymal stem cell function. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 293-303. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. CELULAS-TRONCO MESENQUIMAIS; SMAD3; B-CATENINA; CROSSTALK; PROLIFERACAO; DIFERENCIACAO |
| 958/1507 | US=64 / Câncer Dhodapkar MV. Immunobiology and immunotherapy of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 167-202. (Comtemporary Hematology) ISBN 978-1-934115-82-4. IMUNOLOBIOLOGIA DO MIELOMA MULTIPLO; IMUNOTERAPIA DO MIELOMA MULTIPLO |
| 959/1507 | US=84 / Biol/Mol Glick A, Bae DS, Liu X, Vijayachandra K. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: interaction of oncogenic ras and TGFB1 signaling in cancer: lessons from the multistage skin carcinogenesis model. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 305-15. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGFB1; ONCOGENE RAS; PELE; QUERATINOCITOS; VARIOS ESTAGIOS DA CARCINOGENESE; CANCER DE PELE |
| 960/1507 | US=84 / Biol/Mol Souchelnytskyi S. TGF-B superfamily members in normal and tumor biology: proteomics analysis of TGFB superfamily members. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 319-31. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. PROTEOMICA; SINALIZACAO; FACTOR DE CRESCIMENTO TRANSFORMANTE-B; PROTEINAS MORFOGENETICAS DO OSSO; SMAD |